原发性骨内脑膜瘤切除联合颅骨成形术的长期结局:瑞典多中心人群研究
本研究基于瑞典四家神经外科中心2008–2022年119例原发性骨内脑膜瘤切除联合颅骨成形术患者,回顾性分析长期结局。结果显示16%需再手术的并发症、10%植入物取出、31%肿瘤复发;植入材料选择不影响并发症率,肿瘤生物学侵袭性标志物与并发症及复发风险增加相关。
要点
- 骨内脑膜瘤切除联合颅骨成形术后并发症和复发常见。
- 植入材料选择与并发症率无关,生物学和解剖因素预测不良结局。
- 需再手术并发症占16%,植入物取出占10%,肿瘤复发占31%。
核心结论
- 骨内脑膜瘤切除联合颅骨成形术后手术并发症和肿瘤复发常见。
- 肿瘤生物学和 anatomical 因素而非重建材料是不良结局的最强预测因素。
研究设计与样本
- 人群基础、多中心回顾性队列研究,纳入瑞典四个神经外科部门2008–2022年接受原发性骨内脑膜瘤切除联合颅骨成形术的所有患者,共119例。
- 通过病历审查回顾性收集患者人口学、肿瘤及手术相关数据。
- 使用Cox回归分析手术并发症率和预测因素及肿瘤复发(含残留肿瘤生长)复合结局。
主要发现
- 119例患者中,16%经历需再手术的手术并发症。
- 10%接受植入物取出。
- 31%出现肿瘤复发。
- 参与中心间植入材料选择差异显著,但未影响并发症率。
- 生物学侵袭性标志物与手术并发症和肿瘤复发风险增加相关。
临床怎么用
- 应关注骨内脑膜瘤患者的肿瘤生物学和 anatomical 因素以预测并发症和复发风险。
- 植入材料选择可能不是降低并发症的关键因素。
局限性
- 回顾性研究设计。
- 样本量有限(119例)。
- 数据来自病历审查,可能存在信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies on intraosseous meningiomas requiring cranioplasty have been scarce, and surgical outcomes thus remain poorly characterized. Using a population-based, multicentre cohort of patients who had undergone resection of intraosseous meningioma with concurrent cranioplasty, we aimed to establish long-term outcomes, as well as rates and predictors of complications and tumour recurrence. METHOD: All patients who had undergone primary resection of an intraosseous meningioma with concurrent cranioplasty at four neurosurgical departments in Sweden between 2008 and 2022 were included. Data on patient demographics as well as tumour- and surgery-related data were collected retrospectively by scrutiny of medical records. Rates and predictors of surgical complications, and the composite outcome of tumour recurrence (including growth of residual tumour), were analysed using Cox regression. RESULTS: Of the 119 patients included, 16% experienced surgical complications requiring reoperation, 10% underwent implant explantation, and 31% developed tumour recurrence. Choice of implant material differed significantly across the participating centres but did not influence complication rates. Markers of biological aggressiveness were associated with an increased risk of surgical complications and tumour recurrence. CONCLUSIONS: Surgical complications and tumour recurrence are common following resection of intraosseous meningiomas with concurrent cranioplasty. Rather than the material used for cranial reconstruction, biological and anatomical tumour-related factors were the strongest predictors of adverse outcomes.
引用
- Nilsson RF, Corell A, Muncan E, et al. Long-term outcomes following primary resection of intraosseous meningiomas with concurrent cranioplasty: a population-based Swedish multicentre study. Acta Neurochir (Wien). 2026. PMID: 42470508. doi:10.1007/s00701-026-06987-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。